Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
J Vet Diagn Invest ; 19(2): 168-75, 2007 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-17402611

RESUMEN

The purpose of this study was to characterize light and electron microscopic findings from 9 dogs that had consumed aflatoxin-contaminated commercial dog food from recalled batches. Four dogs died and 5 were euthanized after signs of liver failure. Analysis of feed and liver samples confirmed exposure to aflatoxin. Of the 9 dogs, 8 had classic signs of liver failure, and 1 had signs of liver failure. Enlarged, pale yellow livers were seen macroscopically at necropsy in the dogs with subacute hepatopathy, and cirrhosis was noted in the dog with chronic hepatopathy. Histopathologic findings included hepatic lipidosis, portal fibroplasia, and biliary hyperplasia, which supported a diagnosis of subacute toxic hepatopathy in the 8 symptomatic animals. Marked lobular atrophy, bridging portal fibrosis, and regenerative hepatocellular nodules characterized the dog with chronic hepatopathy. Electron microscopy revealed marked hepatocellular lipid vacuolation and early fibroplasia in the dogs with acute hepatopathy and marked fibrosis and regeneration in the dog with chronic hepatopathy. Analysis of feed for aflatoxin consistently revealed high levels of aflatoxin B1 (range of 223-579 ppb), and hepatic tissue contained elevated levels of aflatoxin B1 metabolite M1 (0.6-4.4 ppb). Although dogs are not commonly affected by aflatoxicosis, they are highly susceptible and can present with classic signs of acute or chronic hepatopathy. Characteristic gross, histologic, and electron microscopic changes help pathologists determine a presumptive toxic insult. Detecting aflatoxins or their metabolites in feed or liver specimens can help confirm the diagnosis of aflatoxicosis.


Asunto(s)
Aflatoxinas/análisis , Alimentación Animal/toxicidad , Enfermedades de los Perros/etiología , Enfermedades Transmitidas por los Alimentos/veterinaria , Animales , Autopsia/veterinaria , Perros , Femenino , Vesícula Biliar/patología , Hígado/patología , Hígado/ultraestructura , Masculino , Tennessee
2.
J Vet Diagn Invest ; 18(6): 590-3, 2006 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-17121089

RESUMEN

Cyclooxygenase-2 (COX-II) is an inducible enzyme that is responsible for the production of prostaglandin E2 (PGE2), which is often upregulated in neoplastic conditions. Expression of COX-II is documented in the majority of human pancreatic adenocarcinomas and in many epithelial neoplasms in humans and animals. The purpose of this study was to assess a series of feline pancreatic adenocarcinomas for the expression of COX-II. Eight feline pancreatic adenocarcinomas (5 poorly differentiated ductular variants and 3 well-differentiated acinar variants) were included. Immunohistochemical staining showed that COX-II was expressed in 2 (both poorly differentiated ductular variants) of the 8 neoplasms (25%). Approximately 10% of the epithelial cells from these 2 neoplasms expressed intense cytoplasmic staining. However, because feline pancreatic adenocarcinoma does not appear to consistently express COX-II, it is not a useful prognostic indicator for this group of feline neoplasms. In addition, COX-II inhibitors are not likely to be effective therapeutics for cats with this neoplasm.


Asunto(s)
Adenocarcinoma/veterinaria , Enfermedades de los Gatos/enzimología , Ciclooxigenasa 2/biosíntesis , Neoplasias Pancreáticas/veterinaria , Adenocarcinoma/enzimología , Adenocarcinoma/patología , Animales , Enfermedades de los Gatos/patología , Gatos , Dinoprostona/metabolismo , Inducción Enzimática , Inmunohistoquímica/veterinaria , Neoplasias Pancreáticas/enzimología , Neoplasias Pancreáticas/patología
3.
Can J Vet Res ; 66(3): 158-64, 2002 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-12146887

RESUMEN

The search for antigens capable of causing immune-complex-mediated glomerulonephritis continues. Modified live-virus vaccines commercially available for veterinary use are a possible source. In this study, repeated vaccination of mink with live-virus vaccines was investigated as a model for vaccine-induced glomerular injury. Three groups of 10-wk-old mink, 15 per group, were vaccinated once with 4-way vaccine against distemper, Pseudomonas aeruginosa infection, botulism and mink viral enteritis. Subsequently, all mink in each group each were vaccinated either with the 4-way vaccine, a monovalent canine distemper vaccine, or saline. Glomerular function was assessed at 2-wk intervals by determining the urinary protein:creatinine (P:C) ratio. Kidney sections taken at necropsy, 20 wk after the 1st vaccination, were examined by light and immunofluorescent microscopy for deposition of immunoglobulin and complement. There was no statistically significant difference between the treated and control groups based on average urinary P:C ratio medians. Light microscopic changes were detected in glomeruli, but Fisher's exact test showed no significant differences between any of the treatment groups. Deposition of immunoglobulin but not complement was significantly more frequent (P < 0.05) in the glomeruli of animals that received multiple injections of the 4-way vaccine than in the glomeruli of those given only the monovalent canine distemper vaccine or saline. These findings suggest that repeated vaccination may increase the glomerular deposition of immunoglobulin. Further studies are required to determine if the increased deposition of immunoglobulin contributes to the development of glomerular damage and to identify the antigens driving production of the deposited immunoglobulin.


Asunto(s)
Glomerulonefritis/veterinaria , Visón/inmunología , Vacunación/veterinaria , Vacunas Atenuadas/efectos adversos , Vacunas Virales/efectos adversos , Animales , Anticuerpos Antivirales/sangre , Botulismo/inmunología , Botulismo/prevención & control , Botulismo/veterinaria , Proteínas del Sistema Complemento/análisis , Creatina/orina , Modelos Animales de Enfermedad , Moquillo/inmunología , Moquillo/prevención & control , Glomerulonefritis/inmunología , Glomerulonefritis/patología , Glomerulonefritis/virología , Inmunoglobulina G/análisis , Riñón/patología , Riñón/virología , Masculino , Visón/virología , Infecciones por Parvoviridae/inmunología , Infecciones por Parvoviridae/prevención & control , Infecciones por Parvoviridae/veterinaria , Proteínas , Proteinuria/patología , Infecciones por Pseudomonas/inmunología , Infecciones por Pseudomonas/prevención & control , Infecciones por Pseudomonas/veterinaria , Distribución Aleatoria , Vacunación/efectos adversos , Vacunas Atenuadas/inmunología , Vacunas Virales/inmunología
4.
Clin Tech Small Anim Pract ; 18(2): 139-44, 2003 May.
Artículo en Inglés | MEDLINE | ID: mdl-12831079

RESUMEN

It is necessary to have a cooperative relationship between the clinician and the pathologist, because information from both is critical for determining the best case management and favorable prognosis. The principle roles of the veterinary pathologist are to describe the submitted tissues, to determine the nature of the tumor, and to assess completeness of surgical margins. Recently, the Council of the American College of Veterinary Pathologists (ACVP) appointed an ad hoc committee on oncology to evaluate oncologists' needs by polling members of the Veterinary Cancer Society (VCS). The committee's vision was to review morphologic, immunologic, and molecular techniques so that veterinary pathologists could meet the current and future diagnostic and prognostic needs of oncologic veterinarians. The factors determined to be most important to the VCS members in selecting a diagnostic pathology provider included, in order of importance: (1) reliability of results; (2) short turnaround-time; (3) easy access for consultation; (4) rapport with pathologist; (5) convenience of service; and (6) cost of service. This manuscript will attempt to review improved morphologic, immunologic, and molecular techniques to provide for the future diagnostic and prognostic needs of oncologic veterinarians.


Asunto(s)
Enfermedades de los Gatos/patología , Enfermedades de los Perros/patología , Neoplasias/veterinaria , Animales , Biopsia/veterinaria , Gatos , Perros , Técnicas de Diagnóstico Molecular/veterinaria , Estadificación de Neoplasias/veterinaria , Neoplasias/patología , Medicina Veterinaria
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA